Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 23%
Hold 38%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co Inc. has experienced a 3% year-over-year increase in same-store admissions due to effective referral source action plans at underperforming facilities, highlighting their strategic initiatives to enhance patient intake. The company is positioned for significant growth, backed by robust demand in the behavioral health sector, successful bed expansions, and the potential for mergers and acquisitions given their strong capitalization. Furthermore, Acadia's plan to reduce capital expenditures by $300 million year-over-year in 2026 is expected to markedly improve cash flow, underpinning a positive financial outlook.

Bears say

Acadia Healthcare Co. has revised its full-year guidance downward due to unexpected increases in PLGL expenses, which are anticipated to persist through 2026, leading to a notable drop in adjusted EBITDA estimates. The company has experienced softening volumes, resulting in a projected FY26 EBITDA that is approximately 5% below previous expectations, and a valuation that reflects this contraction in the forward enterprise multiple. Additionally, Acadia's ongoing challenges with payor reimbursement and rate pressures, compounded by incremental costs, further contribute to a negative outlook on its financial performance.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 23% recommend Buy, 38% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.